Slaby O - Search Results

1

lncRNA PVT1 in the Pathogenesis and Clinical Management of Renal Cell Carcinoma.

Bohosova J, Kubickova A, Slaby O. Bohosova J, et al. Among authors: slaby o. Biomolecules. 2021 Apr 29;11(5):664. doi: 10.3390/biom11050664. Biomolecules. 2021. PMID: 33947142 Free PMC article. Review.

2

Expression of miRNA-106b in conventional renal cell carcinoma is a potential marker for prediction of early metastasis after nephrectomy.

Slaby O, Jancovicova J, Lakomy R, Svoboda M, Poprach A, Fabian P, Kren L, Michalek J, Vyzula R. Slaby O, et al. J Exp Clin Cancer Res. 2010 Jul 7;29(1):90. doi: 10.1186/1756-9966-29-90. J Exp Clin Cancer Res. 2010. PMID: 20609231 Free PMC article.

3

MicroRNAs and their target gene networks in renal cell carcinoma.

Redova M, Svoboda M, Slaby O. Redova M, et al. Among authors: slaby o. Biochem Biophys Res Commun. 2011 Feb 11;405(2):153-6. doi: 10.1016/j.bbrc.2011.01.019. Epub 2011 Jan 11. Biochem Biophys Res Commun. 2011. PMID: 21232526 Review.

4

Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma.

Redova M, Poprach A, Nekvindova J, Iliev R, Radova L, Lakomy R, Svoboda M, Vyzula R, Slaby O. Redova M, et al. Among authors: slaby o. J Transl Med. 2012 Mar 22;10:55. doi: 10.1186/1479-5876-10-55. J Transl Med. 2012. PMID: 22440013 Free PMC article.

5

Identification of MicroRNAs associated with early relapse after nephrectomy in renal cell carcinoma patients.

Slaby O, Redova M, Poprach A, Nekvindova J, Iliev R, Radova L, Lakomy R, Svoboda M, Vyzula R. Slaby O, et al. Genes Chromosomes Cancer. 2012 Jul;51(7):707-16. doi: 10.1002/gcc.21957. Epub 2012 Apr 10. Genes Chromosomes Cancer. 2012. PMID: 22492545

6

HLA-G and HLA-E specific mRNAs connote opposite prognostic significance in renal cell carcinoma.

Kren L, Valkovsky I, Dolezel J, Capak I, Pacik D, Poprach A, Lakomy R, Redova M, Fabian P, Krenova Z, Slaby O. Kren L, et al. Among authors: slaby o. Diagn Pathol. 2012 May 29;7:58. doi: 10.1186/1746-1596-7-58. Diagn Pathol. 2012. PMID: 22640987 Free PMC article.

7

MiR-210 expression in tumor tissue and in vitro effects of its silencing in renal cell carcinoma.

Redova M, Poprach A, Besse A, Iliev R, Nekvindova J, Lakomy R, Radova L, Svoboda M, Dolezel J, Vyzula R, Slaby O. Redova M, et al. Among authors: slaby o. Tumour Biol. 2013 Feb;34(1):481-91. doi: 10.1007/s13277-012-0573-2. Epub 2012 Nov 13. Tumour Biol. 2013. PMID: 23150176

8

miR-155 and miR-484 Are Associated with Time to Progression in Metastatic Renal Cell Carcinoma Treated with Sunitinib.

Merhautova J, Hezova R, Poprach A, Kovarikova A, Radova L, Svoboda M, Vyzula R, Demlova R, Slaby O. Merhautova J, et al. Among authors: slaby o. Biomed Res Int. 2015;2015:941980. doi: 10.1155/2015/941980. Epub 2015 May 3. Biomed Res Int. 2015. PMID: 26064968 Free PMC article.

9

Combination of MiR-378 and MiR-210 Serum Levels Enables Sensitive Detection of Renal Cell Carcinoma.

Fedorko M, Stanik M, Iliev R, Redova-Lojova M, Machackova T, Svoboda M, Pacik D, Dolezel J, Slaby O. Fedorko M, et al. Among authors: slaby o. Int J Mol Sci. 2015 Sep 29;16(10):23382-9. doi: 10.3390/ijms161023382. Int J Mol Sci. 2015. PMID: 26426010 Free PMC article.

10

Efficacy of Sunitinib in Elderly Patients with Metastatic Renal Cell Carcinoma: Data from Real-World Clinical Practice.

Poprach A, Lakomy R, Bortlicek Z, Melichar B, Pavlik T, Slaby O, Vyzula R, Svoboda M, Kiss I, Studentova H, Zemanova M, Fiala O, Kubackova K, Dusek L, Hornova J, Buchler T; Czech Renal Cell Cancer Cooperative Group. Poprach A, et al. Among authors: slaby o. Drugs Aging. 2016 Sep;33(9):655-63. doi: 10.1007/s40266-016-0390-1. Drugs Aging. 2016. PMID: 27541802

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

359 results

Search Page

Filters